Urothelial Cancer
(42756493BLC3001) A Phase 3 Study of Erdafitinib Compared with Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Selected FGFR Gene Aberrations (THOR)
- Details
ClinicalTrials.gov ID:
NCT03390504
Diagnosis Type:
NA
USOR Number:
- Address
11750 W 2nd Place, Suite 160
Lakewood, CO 80228
P: (303) 430-2700